Patterson Companies

Patterson Cos., Inc. provides products, technologies, services, and business solutions to the dental and animal health markets. It operates through the following segments: Dental, Animal Health, and Corporate. The Dental segment provides consumable dental products, equipment and software, turnkey digital solutions, and value-added services to dentists, dental laboratories, institutions, and other healthcare professionals. The Animal Health segment distributes animal health products, services, and technologies to both the production-animal and companion-pet markets. The Corporate segment consists of general and administrative expenses, including home office support costs in areas such as information technology, finance, legal, human resources, and facilities. The company was founded by John Patterson and Myron Fayette Patterson in 1877 and is headquartered in St. Paul, MN.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Patterson Companies Inc. reports strong Q4 performance and outlines growth strategies for fiscal 2024

Patterson Companies Inc. delivered strong financial results for Q4 2023, with a focus on sustained margin improvement and strategic growth opportunities. Despite challenges in free cash flow and market moderation, the company is well-positioned to leverage its strengths and capitalize on opportunities in the dental and animal health segments.

Patterson Companies Inc. reports strong Q2 earnings and focuses on private label growth

Patterson Companies Inc. delivered strong financial performance in Q2 2023, driven by growth in both the Dental and Animal Health segments. The company reaffirmed fiscal '24 earnings guidance and highlighted the potential of private label products. Despite tax and interest rate challenges, the company remains optimistic and focused on strategic initiatives to drive future growth.

Patterson Companies excels in Q3, eyes international growth opportunities

Patterson Companies reported a strong Q3 performance with internal sales growth and margin improvements. Challenges in the Dental segment were offset by growth in the Animal Health segment. The company highlighted strategic acquisitions, leadership appointments, and operational enhancements as key drivers of success. Opportunities lie in stable patient traffic, international investments, and exploring M&A in dental specialties for future growth.

Patterson Companies reports strong Q4 performance and strategic growth focus

Patterson Companies had a robust Q4 performance, showcasing growth in sales and margins. Despite challenges in the companion animal market, the company is strategically positioned for growth through software investments and service enhancements. Opportunities lie in sustained sales growth, margin expansion, and strategic market positioning.

Patterson Companies reports strong Q1 results amidst strategic focus

Patterson Companies delivered strong Q1 '24 results with growth in sales and adjusted EPS. The company is strategically focusing on private label products and efficiency improvements. While facing challenges like deflationary impacts and inflationary pressures, Patterson sees opportunities in Dental equipment growth and continued investments for long-term profitability.

Patterson Companies reports strong Q2 performance amidst market challenges

Patterson Companies delivered a solid performance in Q2 2024, driven by growth in Dental and Animal Health segments.
Despite challenges like macroeconomic headwinds and pricing pressures, the company remains focused on efficiency and driving demand.
Opportunities exist for Patterson to capitalize on market trends, optimize operations, and explore new growth avenues.
Investors should monitor how Patterson navigates challenges and leverages strengths to achieve its revised fiscal guidance.

Patterson Companies reports solid Q3 performance amidst market challenges

Patterson Companies delivered a solid performance in Q3 2024, with a focus on revenue growth, margin expansion, and strategic investments in distribution and software offerings.
While facing challenges in certain segments, the company remains committed to operational efficiency, margin integrity, and long-term growth initiatives.
Opportunities lie in sustaining sales growth, expanding market presence, and capitalizing on improvements in equipment demand and margin enhancement.
Overall, Patterson's strategic focus on growth, efficiency, and innovation positions the company for long-term success in the market.

Patterson Companies Reports Stable Q4, Eyes Strategic Growth

Patterson Companies concluded fiscal 2024 with stable financial performance, facing some headwinds in the Dental segment but offset by gains in Animal Health and strategic tech investments. The company is poised for modest growth in 2025, backed by ongoing investments in high-margin areas and a strong focus on innovation and market expansion.

Patterson Companies addresses challenges in Q1 2025 earnings call

Patterson Companies faced challenges in Q1 2025, with declines in both the Dental and Animal Health segments.
Despite these challenges, management is taking actions to improve performance and profitability for the rest of fiscal 2025.
The company's focus on cost management and operational efficiency is a strength in navigating the current environment.
Opportunities exist in strengthening the companion animal business, improving internal sales, and enhancing cybersecurity measures.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Patterson Cos., Inc. engages in the provision of products, technologies, services, and business solutions to the dental and animal health markets. It operates through the following segments: Dental, Animal Health, and Corporate. The Dental segment provides consumable dental products, equipment and software, turnkey digital solutions, and value-added services to dentists, dental laboratories, institutions, and other healthcare professionals. The Animal Health segment distributes animal health products, services, and technologies to both the production-animal and companion-pet markets. The Corporate segment consists of general and administrative expenses, including home office support costs in areas such as information technology, finance, legal, human resources, and facilities. The company was founded by John Patterson and Myron Fayette Patterson in 1877 and is headquartered in St. Paul, MN.

Patterson Cos. (PDCO) delivered earnings and revenue surprises of 10.53% and 3.26%, respectively, for the quarter ended October 2022.

Patterson Cos. (PDCO) Q2 Earnings Beat Estimates

ST. PAUL, Minn.--( BUSINESS WIRE )--Patterson Companies, Inc. (Nasdaq: PDCO) today reported consolidated net sales of $1.63 billion (see attached Sales Summary for further details) in its fiscal second quarter ended October 29, 2022, a decrease of 1.4 percent compared to the same period last year. Internal sales, which are adjusted for the effects of currency translation, increased 0.7 percent over the prior year period.

Patterson Companies Reports Fiscal 2023 Second Quarter Operating Results

Patterson Cos. (PDCO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.

Earnings Preview: Patterson Cos. (PDCO) Q2 Earnings Expected to Decline

ST. PAUL, Minn.--( BUSINESS WIRE )--Patterson Companies (Nasdaq: PDCO) today announced that it will hold its fiscal 2023 second-quarter earnings conference call on Thursday, December 1, 2022 at 7:30 a.m. CT (8:30 a.m. ET). The company's earnings release will be issued that morning before the market opens.

Patterson Companies Fiscal 2023 Second Quarter Conference Call Scheduled for Thursday, December 1, 2022

Patterson Companies' (PDCO) latest buyout is expected to significantly expand its Animal Health's product offerings.

Patterson Companies' (PDCO) New Buyout to Expand Product Suite

ST. PAUL, Minn.--( BUSINESS WIRE )--Patterson Companies, Inc. (Nasdaq: PDCO), today announced that it has, through a subsidiary, signed an agreement to acquire substantially all of the assets of Dairy Tech, Inc., a Colorado-based company that provides pasteurizing equipment and single-use bags that allow dairy producers to produce, store and feed colostrum for newborn calves, as well as product offerings for beef cattle producers. Upon closing, the acquisition will expand Patterson Animal Health's value-add platform by adding these products and solutions to their suite of offerings.

Patterson Enters Agreement to Acquire Dairy Tech

Patterson Companies' (PDCO) latest buyout is expected to significantly expand its value-add platform.

Patterson Companies (PDCO) Inks Deal to Expand Product Suite

Patterson Enters Agreement to Acquire Relief Services for Veterinary Practitioners and Animal Care Technologies

Patterson Companies Inc. PDCO, -2.12% said Thursday that is has named Don Zurbay as chief executive officer. Zurbay, who was most recently the dental and animal health company's chief financial officer, succeeds Mark Walchirk as CEO.

Patterson Cos. names new CEO, after Mark Walchirk resigns after violating policy, demonstrating poor judgment

Patterson Companies Announces Leadership Transition

Patterson Companies has been hammered in H2 2022, nudging 52-week lows following its latest set of numbers. Investors were quick to punish the stock on weaker top-line growth, despite management retaining FY23 guidance.

Patterson Companies: Unfairly Punished, Mispricing Opportunity Ahead

Patterson's Q1 2023 earnings report disappointed amid weakness in the dental business. The reiterated guidance indicates continued resilience in animal health, though, with dental also benefiting from several post-Q1 tailwinds.

Patterson Companies: Looking Past The Earnings Disappointment

Patterson Companies, Inc. (NASDAQ:PDCO ) Q1 2023 Results Earnings Conference Call September 1, 2022 8:30 AM ET Company Participants John Wright - Vice President, Investor Relations Mark Walchirk - President and Chief Executive Officer Don Zurbay - Chief Financial Officer Conference Call Participants Jason Bednar - Piper Sandler Jonathon Block - Stifel Jeffrey Johnson - Robert W. Baird & Co. Erin Wilson Wright - Morgan Stanley Daniel Clark - Bank of America Merrill Lynch Elizabeth Anderson - Evercore ISI A.J.

Patterson Companies, Inc. (PDCO) Q1 2023 Earnings Call Transcript

Patterson Companies' (PDCO) fiscal first-quarter 2023 results were adversely impacted by unfavorable currency movements.

Patterson Companies (PDCO) Q1 Earnings & Sales Miss Estimates

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies, Inc. (Nasdaq: PDCO) today reported consolidated net sales of $1.52 billion (see attached Sales Summary for further details) in its fiscal first quarter ended July 30, 2022, a decrease of 5.7 percent compared to the same period last year. Internal sales, which are adjusted for the effects of currency translation and the extra week of selling results in the first quarter of fiscal 2022, increased 3.2 percent over the prior year period. Report

Patterson Companies Reports Fiscal 2023 First Quarter Operating Results

Patterson Companies' (PDCO) fiscal first-quarter results are likely to reflect an improvement at the Animal Health segment.

What's in Store for Patterson Companies (PDCO) in Q1 Earnings?

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies (Nasdaq: PDCO) today announced that it will hold its fiscal 2023 first-quarter earnings conference call on Thursday, September 1, 2022 at 7:30 a.m. CT (8:30 a.m. ET). The company's earnings release will be issued that morning before the market opens. To access the live webcast, go to the investor relations section of the company's website, www.PattersonCompanies.com. The fiscal 2023 first-quarter earnings conference call replay will be avail

Patterson Companies Fiscal 2023 First Quarter Conference Call Scheduled for Thursday, September 1, 2022

CONMED

PDCO vs. CNMD: Which Stock Is the Better Value Option?

Investors remain optimistic about Patterson Companies (PDCO) on the back of its strong product line.

Here's Why You Should Buy Patterson Companies (PDCO) Stock

PDCO vs. CNMD: Which Stock Should Value Investors Buy Now?

Patterson Cos. (PDCO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Why Patterson Cos. (PDCO) Could Beat Earnings Estimates Again

Becton, Dickinson and Co.

SmileDirectClub

Here we discuss three stocks from the Dental Supplies industry that are likely to create wealth for investors - BDX, PDCO and SDC.

3 Dental Supplies Stocks to Buy Amid Industry Headwinds

Patterson Cos. (PDCO) reported earnings 30 days ago.

Patterson Cos. (PDCO) Up 2.6% Since Last Earnings Report: Can It Continue?

Reasons to Add Patterson Companies (PDCO) to Your Portfolio

Patterson Companies, Inc. (NASDAQ:PDCO ) Q4 2022 Earnings Conference Call June 29, 2022 8:30 AM ET Corporate Participants John Wright - Vice President, IR Mark Walchirk - President and Chief Executive Officer Don Zurbay - Chief Financial Officer Conference Call Participants Erin Wright - Morgan Stanley Jason Bednar - Piper Sandler Jeff Johnson - Baird Nathan Rich - Goldman Sachs Jon Block - Stifel Kevin Caliendo - UBS Justin Lin - William Blair Elizabeth Anderson - Evercore ISI Operator Good morning. My name is Rob, and I will be your conference operator today.

News for Patterson Companies Stock (PDCO)